$93M Lipitor Antitrust Deal Sparks Dispute Over Fee Division
Attorneys representing a class of buyers in antitrust litigation against Pfizer over the cholesterol medication Lipitor are squabbling over how to divide up to $31 million in attorney fees before a...To view the full article, register now.
Already a subscriber? Click here to view full article